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Cerebello-oculo-renal syndromes (CORSs) and Joubert syndrome (JS) are clinically and genetically heterogeneous
autosomal recessive syndromes that share a complex neuroradiological malformation resembling a molar tooth on
brain axial images, a condition referred to as “molar tooth on imaging” (MTI) or the “molar tooth sign.” The
current literature on these syndromes is complex, with overlapping and incomplete phenotypes that complicate the
selection of clinically homogeneous cases for genetic purposes. So far, only one locus (JBTS1 on 9q34) has been
mapped, in two families with JS. Here, we describe a large consanguineous family with JS and nephronophthisis,
representing a novel cerebello-renal phenotype. We have mapped this condition to the pericentromeric region of
chromosome 11 and have named the locus “CORS2.” The acronym “CORS” is proposed for all loci associated
with JS, CORSs, and related phenotypes sharing the MTI, because this neuroradiological sign seems to be the
unifying feature of these clinically heterogeneous syndromes.
Cerebello-oculo-renal syndromes (CORSs) are a group
of autosomal recessive syndromes characterized by the
variable association of brain, eye, and kidney abnor-
malities, plus occasional malformations in other organs,
such as the liver (Chance et al. 1999; Satran et al. 1999).
Neuroradiologically, these syndromes share a complex
brain stem malformation characterized by the appear-
ance, on brain magnetic resonance imaging (MRI), of a
form resembling a molar tooth, a condition referred to
as “molar tooth on imaging” (MTI) or the “molar tooth
sign.” The MTI consists of cerebellar vermian hypo-
plasia/aplasia, thickened and reoriented superior cere-
bellar peduncles, and an abnormally large interpedun-
cular fossa, giving the appearance of a molar tooth on
transaxial slices (Maria et al. 1997). The phenotypic pre-
sentation of CORSs is highly heterogeneous.Neurological
features can include ataxia, hypotonia, psychomotor de-
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velopmental delay, oculomotor disorders (such as ocu-
lomotor apraxia and nystagmus), and changes in the
respiratory rhythm that appear mainly in the neonatal
period. Ocular abnormalities comprise Leber congenital
amaurosis, other noncongenital and less speciﬁc reti-
nopathies, and chorioretinal colobomas, with a clinical
presentation ranging from blindness soon after birth to
a mild reduction of visual acuity at a later age. Renal
abnormalities consist of either cystic dysplastic kidneys
or juvenile nephronophthisis and can be asymptomatic
or mildly symptomatic until adolescence, when chronic
renal failure may occur. Hepatic ﬁbrosis is sometimes
present, as are other distinctive malformations (skeletal
abnormalities, congenital heart defects, tongue tumors,
and various CNS malformations). CORSs are often
considered as variants of Joubert syndrome (JS [MIM
213300]) (also known as “Joubert-Boltshauser syn-
drome”), which is characterized only by neurological
signs plus the MTI (Saraiva and Baraitser 1992; Chance
et al. 1999; Maria et al. 1999a; Satran et al. 1999).
However, retinal involvement has been frequently de-
scribed in patients with JS (type B), and a subgroup of
these patients also manifested renal abnormalities (Sar-
aiva and Baraitser 1992; Steinlin et al. 1997; Satran et
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Table 1
Clinical and Genetic Features of JS and Most Frequent CORSs, Showing the High Degree of Clinical Overlap among Syndromes
Type and Speciﬁcs of Anomaly JS Type A JS Type B Senior-Lo¨ken COACHa Arima COGAN
Cerebello-
Renalb
Neuroimaging:
Vermian hypoplasia/aplasia      () 
MTI   /? /? /? ? 
Other CNS malformations () () () () ()  
Brain:
Hypotonia      () 
Psychomotor retardation   ()  () () 
Ataxia   ()  () () 
Oculomotor abnormalities () () () () ()  
Episodic hyperpnea () () () () ()  
Kidney:
Nephronophthisis      () 
Cystic dysplastic kidney  ()     
Eye:
Leber amaurosis/other retinopathy  / /  /  
Chorio-retinal colobomas () ()   ()  
Other:
Hepatic ﬁbrosis   ()  ()  
Other malformations () () () () ()  
Genetics JBTS1,
other loci
JBTS1, CORS2,
other loci
NPHP1-3-4,
other loci
? ? NPHP1,
other loci
CORS2,
other loci?
NOTE.— p always present; () p not always present;  absent; ? p unknown; /? p results of neuroradiological examination not
described in some cases.
a COACH p cerebellar vermis hypoplasia/aplasia, oligophrenia, atiaxia congenita, coloboma ocular, and hepatic ﬁbrosis.
b Present family.
al. 1999; Sztriha et al. 1999). Clinical diagnostic criteria
for JS and CORSs have been established, but incomplete
and overlapping phenotypes, difﬁcult to frame within a
speciﬁc syndrome, have often been described. Intrafam-
ilial phenotypic variability is also present in JS and
CORSs. Discordance between affected siblings was re-
ported for several clinical features, such as retinopathy,
oculomotor apraxia, and respiratory rhythm changes
(Steinlin et al. 1997; Pellegrino et al. 1999; Satran et al.
1999; Sztriha et al. 1999). This wide clinical heteroge-
neity has led to considerable uncertainty in the nosologic
delineation of CORSs, especially in relation to the JS
phenotype (table 1).
The present classiﬁcation of CORSs remains complex,
making it difﬁcult to pool families together for gene-
mapping efforts. In fact, a genomewide search in 10
small families with JS failed to detect signiﬁcant linkage.
Families were not clinically homogeneous, because some
patients had additional renal or ocular involvement
(Chance et al. 1999). A different approach, based on
direct mutation screening of candidate genes (such as
genes involved in cerebellar development) in patients
with sporadic JS and in small families with the syn-
drome, has not proved fruitful so far (Pellegrino et al.
1997; Blair et al. 2002). This could be due to the dif-
ﬁculty of selecting suitable candidate genes solely on the
basis of their expected function and expression pattern,
given the limited knowledge of the underlying patho-
genetic mechanisms of these syndromes.
A powerful approach toward the identiﬁcation of re-
cessive disease genes is homozygosity mapping in large
consanguineous families, but such families are rare. Since
1999, only one locus (JBTS1) has been mapped to chro-
mosome 9q34.3, in two large inbred families with JS.
All patients presented with ataxia, hypotonia, severe
psychomotor delay, and oculomotor abnormalities. In
one patient, a retinopathy was also present. Neuroim-
aging showed the typical MTI (Saar et al. 1999; Sztriha
et al. 1999). Linkage to JBTS1 was excluded in several
other families with JS, supporting genetic heterogeneity
(Saar et al. 1999; Blair et al. 2002). Meanwhile, four
genetic loci responsible for isolated nephronophthisis
(the most frequent inherited cause of chronic renal fail-
ure in children) have been identiﬁed on chromosomes
2q13 (NPHP1), 9q22-31 (NPHP2), 3q22 (NPHP3), and
1p36 (NPHP4); and two genes (nephrocystin [NPHP1]
and nephroretinin [NPHP4]) have been cloned (Hilde-
brandt et al. 1997; Haider et al. 1998; Omran et al.
2000; Mollet et al. 2002; Otto et al. 2002). Several fam-
ilies presenting with nephronophthisis associated with
Leber congenital amaurosis (Senior-Lo¨ken syndrome
[MIM 266900]) have shown linkage to the NPHP3 or
NPHP4 loci (Omran et al. 2002; Schuermann et al.
2002). Moreover, deletions or point mutations in the
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NPHP1 gene have been reported in patients with spo-
radic nephronophthisis and a milder form of retinopathy
(Caridi et al. 1998) and in patients with nephronoph-
thisis and congenital oculomotor apraxia (COGAN syn-
drome [MIM 257550]) (Saunier et al. 1997; Betz et al.
2000). The latter phenotype was also described in a fam-
ily carrying a heterozygous mutation in the NPHP4 gene
(Mollet et al. 2002). Unfortunately, neurological and
neuroradiological data are not reported for most of these
patients.
A deﬁnite association of JS with proven MTI and ne-
phronophthisis but without retinal involvement has
never been reported within the spectrum of CORSs.
Here, we describe a large consanguineous family from
Sicily with a syndrome characterized by neurological in-
volvement, juvenile nephronophthisis, and the typical
MTI, and we report the mapping of a novel locus to the
pericentromeric region of chromosome 11. Four affected
individuals (three affected sibs and a maternal uncle)
were identiﬁed. A genealogical study traced the origin
of the family to a common ancestral couple six gener-
ations back. The pedigree is shown in ﬁgure 1.
All four patients presented with nystagmus and ocular
motor apraxia, with impairment of smooth pursuit and
saccades; one (patient VI:1) also had bilateral ptosis and
strabismus. Neonatal irregular breathing was never re-
ported. Head circumference was within normal values,
and no dysmorphic features were present. All patients
had developmental delay and moderate-to-severe psycho-
motor retardation, hypotonia with well-preserved deep
tendon reﬂexes, and truncal ataxia. Brain MRI revealed
cerebellar vermian aplasia and the MTI (ﬁgure 2).
All four patients had renal involvement. Patient V:7
(age 26 years) developed acute renal failure at the age
of 17 years and underwent renal transplantation a few
months later. Histological examination showed tubular
basement membrane disintegration, tubular atrophy,
and interstitial ﬁbrosis; a diagnosis of juvenile nephron-
ophthisis was made. Patient VI:1 (age 17 years) devel-
oped mild polyuria and polydipsia in late childhood.
Renal ultrasonography showed kidneys of normal size,
with increased echogenicity and normal corticomedul-
lary differentiation. A urinary concentration test after
intranasal administration of DDAVP (1-desamino-8-D-
arginine vasopressin) showed a maximum osmolarity of
450 mOsm/kg H2O (normal values 1850 mOsm/kg
H2O), indicating defective urinary concentration capac-
ity. At the age of 15 years, she developed chronic renal
failure, but clinical symptoms did not worsen over time.
The other two patients (VI:2 and VI:3), aged 12 and 8
years, are clinically asymptomatic, but the DDAVP con-
centration test revealed pathological values in both
cases, the maximum osmolarity being 660 and 490
mOsm/kg H2O, respectively. In patient VI:3, renal ul-
trasonography showed increased kidney echogenicity.
Renal cysts were not detected in any of the patients.
Ocular examinations (electroretinogram, visual evoked
potentials, and inspection of the fundus oculi) yielded
normal results in all patients, ruling out a possible ocular
involvement (such as a retinopathy or chorioretinal
colobomas).
After informed consent was obtained, blood was sam-
pled from the 4 patients and from 11 healthy family
members. Linkage to JBTS1 and to all NPHP loci was
excluded by genotyping microsatellite markers spanning
the linked intervals; 400 microsatellite markers covering
all autosomes (ABI PRISM Linkage Mapping Set, ver-
sion 2) were then analyzed in the four patients. These
individuals were homozygous for the same allele at 13
marker loci (6 contiguous markers on chromosome 11
and 7 isolated markers, 1 each on chromosomes 2, 4,
5, 7, 9, 13, and 15). The regions surrounding these loci
were saturated with closely spaced microsatellite mark-
ers from theMarshﬁeld genetic map. All available family
members were genotyped, and haplotypes were con-
structed, assigning phase on the basis of the minimum
number of recombinants. Two-point LOD scores were
generated using the FASTLINK version of the MLINK
program, assuming equal male-female recombination
rate, autosomal recessive inheritance, a gene frequency
of 0.001 with complete penetrance, and equal allele fre-
quencies for each marker (Cottingham et al. 1993). A
combination of negative LOD scores and the detection
of different haplotypes carried by the affected individ-
uals allowed exclusion of all the autosomes except the
pericentromeric region of chromosome 11 (ﬁg. 1). This
region was further saturated with novel polymorphic
dinucleotide repeats selected from the Human Genome
Working Draft, using the tandem repeats ﬁnder software
described by Benson (1999). The position of these novel
markers on the physical map of human chromosome 11
is reported in table 2; primers and PCR conditions are
available on request.
All four affected individuals in the family shared a
large region of homozygosity betweenmarkersD11S4083
and J63302, identifying a novel locus. To prevent pos-
sible confusion in the nomenclature of new genetic loci
that could result from the signiﬁcant clinical and genetic
heterogeneity of these syndromes, we propose to adopt
the acronym “CORS” for loci identiﬁed in all cerebello-
oculo-renal syndromes sharing the pathognomonic
MTI, including JS and incomplete phenotypes such as
COGAN and cerebello-renal syndromes. So far, only
JBTS1 has been clearly associated with the MTI (Saar
et al. 1999; Sztriha et al. 1999). We therefore named the
present locus “CORS2,” suggesting “CORS1” as an al-
ternative symbol for the JBTS1 locus on chromosome
9q34.
The maximum LOD score obtained was 3.96, with a
recombination fraction (v) of 0.00, for marker D11S1313
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Figure 1 Pedigree of the family and haplotypes of marker loci spanning the CORS2 locus on chromosome 11p11.2-q12.3. Blackened
symbols denote affected individuals. A thin horizontal bar above a symbols indicates a member of the family who was examined clinically and
who provided a blood sample. The blackened bar denotes the disease-associated haplotype. Arrow indicates the proband.
667
Figure 2 Results of brain MRI in affected individuals. A, Patient VI:1. Axial T2-weighted image at the pontine level shows thickened
superior cerebellar peduncles and umbrella-shaped fourth ventricle, giving the appearance of a molar tooth. B, Patient VI:1. Axial T2-weighted
image at the mesencephalic level shows an abnormally deep interpeduncular fossa and thickened superior cerebellar peduncles. C, Patient VI:
3. D, Patient VI:2. Coronal T2-weighted images in panels C and D show cerebellar hemispheres separated only by a thin sagittal cleft (buttock
sign). E, Patient VI:3. Sagittal T1-weighted image demonstrates cerebellar vermian aplasia, a fourth ventricle enlarged and deformed. F, Patient
VI:3. Sagittal T1-weighted image demonstrates prominent superior cerebellar peduncles running horizontally toward the brain stem.
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Table 2
Pairwise LOD Scores between CORS2 and Markers on
Chromosome 11p11.2-q12.3
MARKER cMa Mbb
LOD SCORE AT v p
.0 .01 .05 .1 .2 .3 .4
D11S4083 47.06 37.171  2.37 2.67 2.49 1.84 1.10 .42
J39003 NA 39.003  1.64 1.98 1.83 1.22 .58 .18
J42721 NA 42.721  2.00 2.34 2.19 1.55 .82 .26
D11S1993 54.09 44.293  2.23 2.55 2.37 1.74 1.03 .39
D11S986 56.76 45.399 3.74 3.65 3.28 2.81 1.85 .92 .24
D11S4109 58.40 48.479 1.63 1.58 1.37 1.12 .64 .29 .10
D11S1313 58.40 57.747 3.96 3.87 3.52 3.07 2.14 1.21 .41
J58329 NA 58.329 3.49 3.41 3.07 2.64 1.76 .91 .26
J59897 NA 59.897 3.44 3.36 3.02 2.59 1.71 .87 .25
D11S4191 60.09 61.513 2.84 2.79 2.55 2.24 1.59 .92 .33
J61808 NA 61.808 2.80 2.74 2.51 2.21 1.56 .89 .30
J61943 NA 61.943 1.57 1.53 1.38 1.18 .78 .40 .11
D11S1765 61.78 62.291 2.80 2.74 2.51 2.20 1.56 .89 .30
D11S4076 62.62 62.938 2.80 2.74 2.51 2.21 1.56 .89 .30
J63302 NA 63.302 1.12 1.09 .99 .85 .59 .35 .15
D11S1883 65.05 64.949  1.11 1.55 1.52 1.13 .64 .24
NOTE.—Novel polymorphic dinucleotide repeats selected from the
Human Genome Working Draft using the Tandem Repeat Finder soft-
ware; names have been arbitrarily assigned.
a Position of the microsatellite marker on the genetic map. NA p
information not available because markers are newly generated.
b Position of the microsatellite marker on the physical map.
(table 2). A substantial reﬁnement of the linked region
was obtained by considering haplotypes in individual
V:9, who is the healthy sister of patient V:7 and shares
with him a region of homozygosity at the upper end
of the interval. A recombination event between mark-
ers D11S1993 and D11S986 on her maternal chromo-
some marks the upper boundary of the CORS2 locus,
which maps to an 11-cM interval between ﬂanking
markers D11S1993 andD11S1883, spanning cytogenetic
bands 11p11.2-q12.3. The linked region covers 20.6 Mb
on the physical map of chromosome 11 and comprises
∼5 Mb of centromeric DNA.
The lower extent of the CORS2 locus could be further
reﬁned by analyzing haplotypes in unaffected family
members V:3 and V:5. In fact, individual V:5 (father of
the three affected sibs) and his brother (individual V:3)
also share with the patients a region of homozygosity,
from D11S4191 to J63302. The identiﬁcation of a com-
mon ancestor in the family and the high degree of con-
sanguineous marriage among family members strongly
suggests that this region of homozygosity is also due to
identity by descent, thereby identifying D11S4191 as the
lower ﬂanking marker of the linked interval and reduc-
ing the locus to 6 cM/17.2 Mb, still encompassing the
centromere. However, in this case, identity by descent
cannot be deﬁnitely proved, because of the lack of an
affected individual in the sibship of V:3 and V:5, which
accounts for the positive LOD scores obtained for mark-
ers D11S4191 to J63302 (table 2).
The coexistence of renal and cerebellar abnormalities
in the present family could facilitate the selection of can-
didate genes, because the pathogenetic mechanism lead-
ing to nephronophthisis has been partly revealed by
functional studies on nephrocystin and nephroretinin
proteins. Nephrocystin, which is encoded by the NPHP1
gene, contains several domains of protein-protein inter-
action. It is thought to be involved in focal adhesion
and/or adherence-junction signaling, through its inter-
action with the p130cas protein, a major mediator of
focal adhesion assembly, and with E-cadherin, a consti-
tutive protein of adherence junctions of epithelial cells
(Hildebrandt and Otto 2000). Nephroretinin, a product
of the NPHP4 gene, has a proline-rich domain, and it
has been shown to interact with the SH3 domain of
nephrocystin, suggesting a role as an additional partner
of the nephrocystin multimolecular signaling complex
that regulates cell-cell and cell-matrix adhesion (Mollet
et al. 2002).
Candidate genes for CORS2 are CTNND1 (coding
for p120ctn catenin, a protein that binds to E-cadherin
and is implicated in cell-cell adhesion and ligand-induced
receptor signaling) and LOC90139 (coding for a tetra-
spanin similar to uroplakin1, an integral protein playing
a major role in urinary epithelium adhesion mecha-
nisms). Also, other possible candidate genes within
the CORS2 locus code for proteins expressed in the
CNS and the kidney and putatively involved in neurite
growth, focal adhesion processes, and signal trans-
duction pathways (MDK, ARHGAP1, Pacsin 3, and
MADD). Yet the CORS2 physical region is still large
and contains 1100 genes, several of which are of un-
known function. The identiﬁcation of other families
linked to CORS2 would greatly help to reﬁne this genetic
locus, thereby reducing the number of possible candidate
genes. Because large informative families are rare, link-
age efforts often rely on pooling small families. Recently,
a genomewide search in 20 small families with JS/CORSs
and the MTI showed evidence of linkage to the same
pericentromeric region of chromosome 11 (CORS2) in
3 consanguineous families (Keeler et al. 2003 [in this
issue]). The independent identiﬁcation of the same locus
in four distinct families by use of different approaches
strongly suggests that CORS2 could be a relevant locus
for JS and CORSs. However, further work on additional
families is needed to assess the prevalence of CORS2
and to establish genotype-phenotype correlations.
This is the ﬁrst report of a pure cerebello-renal syn-
drome with a neuroradiologically proven MTI. Saraiva
and Baraitser (1992) divided patients with JS into two
groups, based on the absence (type A) or presence (type
B) of retinopathy, and suggested that renal involvement
in JS occurs only when retinal abnormalities are also
present. Nevertheless, occasional descriptions of cere-
bello-renal phenotypes can be found in the literature,
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although neuroradiological images showing theMTI are
never presented in these cases. Maria and colleagues
(1999b) described six patients with JS who had renal,
but not retinal or other ocular, abnormalities; a clinical
description of the neurological and renal phenotype in
these patients was not provided. The two siblings with
JS and nephronophthisis described by Steinlin and co-
workers (1997) did not have a retinopathy, but fundus
oculi examination revealed a “fundus ﬂavus,” repre-
senting a mild, clinically asymptomatic retinal abnor-
mality. Electroretinogram performed in one sib at age 1
year showed normal results, and a follow-up examina-
tion at age 10 years still did not reveal signs of ocular
involvement (Steinlin et al. 1997). In two of the four
patients with COGAN syndrome and nephronophthisis
who carried deletions in the NPHP1 gene, oculomotor
abnormalities were associated with motor delay, cere-
bellar ataxia, and/or mild mental retardation, and, in
two of them, vermian hypoplasia was described. Each
of these patients had at least one sib with isolated ne-
phronophthisis, suggesting that this phenotype could
also be part of the spectrum of CORSs (Saunier et al.
1997; Satran et al. 1999).
The rare occurrence of pure cerebello-renal syndromes
could result, in part, from the underdiagnosis of renal
involvement in patients with JS. In the present family,
the two youngest patients, ages 8 and 10 years, did not
show any clinical sign of renal involvement, such as poly-
uria or polydipsia. Creatinine and other parameters of
kidney function were within normal limits, and results
of kidney ultrasound were normal, at least in patient
VI:2. The presence of a positive family history for ne-
phronophthisis prompted us to perform a DDAVP test,
which showed an abnormal urinary concentration abil-
ity in both patients. This is in line with the natural his-
tory of isolated juvenile nephronophthisis, which can be
asymptomatic or mildly symptomatic for years before
leading to end-stage renal disease, usually in late child-
hood or adolescence (Hildebrandt and Otto 2000).
In agreement with the research directions recom-
mended by the Joubert Syndrome Workshop in 1998
(Spinella 1999), we believe that the establishment of an
internationally recognized diagnostic algorithm, to be
followed in each patient who is suspected of having
CORS or MTI, is a crucial step toward obtaining a pre-
cise phenotypic characterization of these syndromes, fa-
cilitating the selection of homogeneous families to be
pooled for genetic studies. The application of a stan-
dardized diagnostic protocol would allow information
about families with CORSs to be shared among different
research groups, in an international effort aimed at col-
lecting large numbers of informative families, thus op-
timizing linkage approaches. We also propose a speciﬁc
genetic nomenclature (“CORS”) for all loci involved in
CORSs, JS, and related syndromes sharing the MTI, be-
cause this peculiar neuroradiological sign appears to be
the unifying and characteristic feature of these clinically
heterogeneous disorders.
Acknowledgments
We thank Dr. Carmelo Fede, for performing DDAVP test in
patients, and Dr. Daniela Zuccarello, for collecting blood sam-
ples of some family members. We are grateful to Dr. Joseph
Gleeson and collaborators for exchanging manuscripts prior
to submission. This work was partly supported by the Italian
Ministry of Health (Ricerca Finalizzata 2002 n. ICS160.3/
RF02.160; Ricerca Corrente 2003) and the Italian Ministry of
University and Research (COFIN 2002).
Electronic-Database Information
Accession numbers and URLs for data presented herein are
as follows:
Center for Medical Genetics, Marshﬁeld Medical Research
Foundation, http://research.marshﬁeldclinic.org/genetics/ (for
chromosome 11 genetic map)
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim/ (for COGAN syndrome, JS, and
Senior-Lo¨ken syndrome)
UCSC Genome Bioinformatics, http://genome.cse.ucsc.edu/
(for chromosome 11 physical map; November 2002)
References
Benson G (1999) Tandem repeats ﬁnder: a program to analyze
DNA sequences. Nucleic Acids Res 27:573–580
Betz R, Rensing C, Otto E, Mincheva A, Zehnder D, Lichter
P, Hildebrandt F (2000) Children with ocular motor apraxia
type COGAN carry deletions in the gene (NPHP1) for ju-
venile nephronophthisis. J Pediatr 136:828–831
Blair IP, Gibson RR, Bennett CL, Chance PF (2002) Search
for genes involved in Joubert syndrome: evidence that one
or more major loci are yet to be identiﬁed and exclusion of
candidate genes EN1, EN2, FGF8 and BARHL1. Am J Med
Genet 107:190–196
Caridi G, Murer L, Bellantuono R, Sorino P, Caringella DA,
Gusmano R, Ghiggeri GM (1998) Renal-retinal syndromes:
association of retinal anomalies and recessive nephron-
ophthisis in patients with homozygous deletions of the
NPH1 locus. Am J Kidney Dis 32:1059–1062
Chance PF, Cavalier L, Satran D, Pellegrino JE, Koenig M,
Dobyns WB (1999) Clinical nosologic and genetic aspects
of Joubert and related syndromes. J Child Neurol 14:660–
666
Cottingham RW Jr, Idury RM, Scha¨ffer AA (1993) Faster se-
quential genetic linkage computations. Am J HumGenet 53:
252–263
Haider NB, Carmi R, Shalev H, Shefﬁeld VC, LandauD (1998)
A Bedouin kindred with infantile nephronophthisis dem-
onstrates linkage to chromosome 9 by homozygosity map-
ping. Am J Hum Genet 63:1404–1410
Hildebrandt F, Otto E, Rensing C, Nothwang HG, Vollmer
670 Am. J. Hum. Genet. 73:663–670, 2003
M, Adolphs J, Hanusch H, Brandis M (1997) A novel gene
encoding an SH3 domain protein is mutated in nephron-
ophthisis type 1. Nat Genet 17:149–153
Hildebrandt F, Otto E (2000) Molecular genetics of nephron-
ophthisis and medullary cystic kidney disease. J Am Soc
Nephrol 11:1753–1761
Keeler LC,Marsh SE, Leeﬂang EP,Woods CG, Sztriha L (2003)
Linkage analysis in families with Joubert syndrome plus
oculo-renal involvement identiﬁes the CORS2 locus on chro-
mosome 11p12-q13.3. Am J Hum Genet 73:656–662 (in
this issue)
Maria BL, Boltshauser E, Palmer SC, Tran TX (1999a) Clinical
features and revised diagnostic criteria in Joubert syndrome.
J Child Neurol 14:583–591
Maria BL, Hoang KB, Tusa RJ, Mancuso AA, Hamed LM,
Quisling RG, Hove MT, Fennell EB, Booth-Jones M, Ring-
dahl DM, Yachnis AT, Creel G, Frerking B (1997) “Joubert
syndrome” revisited: key ocular motor signs with magnetic
resonance imaging correlation. J Child Neurol 12:423–430
Maria BL, Quisling RG, Rosainz LC, Yachnis AT, Gitten J,
Dede D, Fennell E (1999b) Molar tooth sign in Joubert
syndrome: clinical, radiological, and pathologic signiﬁcance.
J Child Neurol 14:368–376
Mollet G, Salomon R, Gribouval O, Silbermann F, Bacq D,
Landthaler G, Milford D, Nayir A, Rizzoni G, Antignac C,
Saunier S (2002) The gene mutated in juvenile nephron-
ophthisis type 4 encodes a novel protein that interacts with
nephrocystin. Nature Genet 32:300–305
Omran H, Fernandez C, Jung M, Ha¨ffner K, Fargier B, Vil-
laquiran A, Waldherr R, Gretz N, Brandis M, Ruschendorf
F, Reis A, Hildebrandt F (2000) Identiﬁcation of a new gene
locus for adolescent nephronophthisis, on chromosome
3q22 in a large Venezuelan pedigree. Am J Hum Genet 66:
118–127
Otto E, Hoefele J, Ruf R, Mueller AM, Hillet KS, Wolf MTF,
Schuermann MJ, Becker A, Birkenha¨ger R, Sudbrak R, Hen-
nies HC, Nu¨rnberg P, Hildebrandt F (2002) A gene mutated
in nephronophthisis and retinitis pigmentosa encodes a
novel protein, nephroretinin, conserved in evolution. Am J
Hum Genet 71:1161–1167
Pellegrino JE, Lensch MW, Muenke M, Chance PF (1997)
Clinical and molecular analysis in Joubert syndrome. Am J
Med Genet 72:59–62
Saar K, Al-Gazali L, Sztriha L, Ru¨eschendorf F, Nur-E-Kamal
M, Reis A, Bayoumi R (1999) Homozygosity mapping in
families with Joubert syndrome identiﬁes a locus on chro-
mosome 9q34.3 and evidence for genetic heterogeneity. Am
J Hum Genet 65:1666–1671
Saraiva JM, Baraitser M (1992) Joubert syndrome: a review.
Am J Med Genet 43:726–731
Satran D, Pierpoint MEM, Dobyns WB (1999) Cerebello-
oculo-renal syndromes including Arima, Senior-Lo¨ken and
COACH syndromes: more than just variants of Joubert syn-
drome. Am J Med Genet 86:459–469
Saunier S, Morin G, Calado J, Bennessy F, Silbermann F, An-
tignac C (1997) Large deletions of the NPH1 region in CO-
GAN syndrome (CS) associated with familial juvenile neph-
ronophthisis (NPH). Am J Hum Genet Suppl 61:A346
Schuermann MJ, Otto E, Becker A, Saar K, Ru¨schendorf F,
Polak BC, Ala-Mello S, Hoefele J, Wiedensohler A, Haller
M, Omran H, Nu¨rnberg P, Hildebrandt F (2002) Mapping
of gene loci for nephronophthisis type 4 and Senior-Lo¨ken
syndrome, to chromosome 1p36. Am J Hum Genet 70:
1240–1246
Spinella GM (1999) Research directions: follow-up of the Jou-
bert SyndromeWorkshop, October 21, 1998. J ChildNeurol
14:667–668
Steinlin M, Schmid M, Landau K, Boltshauser E (1997) Fol-
low-up in children with Joubert syndrome. Neuropediatrics
28:204–211
Sztriha L, Al-Gazali LI, Aithala GR, Nork M (1999) Joubert’s
syndrome: new cases and review of clinicopathologic cor-
relation. Pediatr Neurol 20:274–281
